Physician profile
Mohammad Naeem
NPI 1235172354
$1,382.16
in general payments reported to CMS, 2019-2025
17 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $94.59 · 2021: $366 · 2022: $32.18 · 2023: $199 · 2024: $74.17 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.02 | 2021-2025 | |
| Allergan, INC. | $267.65 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $247.94 | 2020-2025 | Trintellix |
| Lundbeck LLC | $84.41 | 2019-2021 | |
| Almatica Pharma LLC | $42.17 | 2024-2025 | Loreev Xr |
| Alkermes, INC. | $39.47 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.22 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.63 | 2020-2025 | Xifaxan |
| Neuronetics, INC. | $35.35 | 2019 | |
| Siemens Medical Solutions USA, INC. | $34.58 | 2025 | Somatom Go.Top |
| Brainsway USA INC | $31.03 | 2023 | |
| Neurocrine Biosciences, INC. | $29.43 | 2025 | |
| Vanda Pharmaceuticals INC. | $21.99 | 2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $18.32 | 2020 | |
| Merck Sharp & Dohme LLC | $17.62 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.53 | 2022 | |
| Pfizer INC. | $14.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Naeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.